Bococizumab is a cutting-edge anti-PCSK9 antibody specifically developed to combat hypercholesterolemia. It therapeutic agent interacts with the PCSK9 protein, a key regulator of cholesterol levels. By blocking the https://junaidblfh560168.wikicommunications.com/7345248/bococizumab_a_novel_anti_pcsk9_antibody_for_hypercholesterolemia